Floatz logo

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER

Myeloma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkinsmonoclonal_antibodyEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

498 Active assets in the Myeloma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Jonsson Comprehensive Cancer Center
Phase 4BBB
Inno-206
University of Arkansas
Phase 3BBB
Hyaluronidase fihj
Massachusetts General Hospital
Phase 4BBB
Busulphan
M.D. Anderson Cancer Center
Phase 4BBB
Filanesib
PETHEMA Foundation
Phase 2BBB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G2, ANTI-(HUMAN CD19 (ANTIGEN)) (SYNTHETIC HUMAN MONOCLONAL MEDI-551 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN MONOCLONAL MEDI-551 .KAPPA.-CHAIN, DIMER is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
B
Indicative ·
57 / 100
View asset →
diffuse large B-cell lymphomaDormant
CCC
Indicative ·
54 / 100
View asset →
autoimmune encephalitisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →